| Validation of phosphodiesterase-10 as a novel target for pulmonary arterial hypertension via highly selective and subnanomolar inhibitors YY Huang, YF Yu, C Zhang, Y Chen, Q Zhou, Z Li, S Zhou, Z Li, L Guo, ... Journal of medicinal chemistry 62 (7), 3707-3721, 2019 | 39 | 2019 |
| The Pol III transcriptome: basic features, recurrent patterns, and emerging roles in cancer S Zhou, K Van Bortle Wiley Interdisciplinary Reviews: RNA 14 (5), e1782, 2023 | 22 | 2023 |
| Prostacyclin facilitates vascular smooth muscle cell phenotypic transformation via activating TP receptors when IP receptors are deficient Z Li, W Luo, S Fang, X Chen, T Lin, S Zhou, L Zhang, W Yang, Z Li, J Ye, ... Acta Physiologica 231 (2), e13555, 2021 | 11 | 2021 |
| A Combinatorial Regulatory Platform Determines Expression of RNA Polymerase III Subunit RPC7α (POLR3G) in Cancer R Cheng, S Zhou, R KC, S Lizarazo, L Mouli, A Jayanth, Q Liu, ... Cancers 15 (20), 4995, 2023 | 3 | 2023 |
| Evidence of RNA polymerase III recruitment and transcription at protein-coding gene promoters KC Rajendra, R Cheng, S Zhou, S Lizarazo, DJ Smith, K Van Bortle Molecular cell 84 (21), 4111-4124. e5, 2024 | 2 | 2024 |
| Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations S Zhou, S Lizarazo, L Mouli, S Chorghade, R Cheng, KC Rajendra, ... bioRxiv, 2024 | | 2024 |
| Evidence of RNA polymerase III recruitment and transcription at protein-coding gene promoters R KC, R Cheng, S Zhou, S Lizarazo, D Smith, K Van Bortle bioRxiv, 2024.06. 08.598009, 2024 | | 2024 |
